Copyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=bvfLatest Financial News for BIOVAIL CORPen-usThu, 17 Dec 2009 12:22:50 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/ud?s=BVFyahoo_finance/3875169817Thu, 17 Dec 2009 12:22:50 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=13bt1huv5/*http%3A//www.fool.com/investing/dividends-income/2009/12/12/one-investment-to-avoid-in-todays-market.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/772796953Sat, 12 Dec 2009 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh55297_2009-12-04_14-53-53_n02546120_newsml&rpc=44&type=marketsNewsyahoo_finance/856145953Fri, 4 Dec 2009 14:53:53 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/rb/091204/business_us_hedgefunds_sac.html?.v=1B.J. Kang may be the most feared man on Wall Street. When Bernie Madoff, who engineered history's biggest Ponzi scheme, was arrested, FBI Special Agent Kang was right at his side. And less than a year later, there was Kang again, in a "perp walk," shuffling alongside a handcuffed Raj Rajaratnam, the former hedge fund star at Galleon accused of earning millions off illegally obtained stock tips.yahoo_finance/188032077Fri, 4 Dec 2009 13:30:14 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12qq6m82q/*http%3A//www.fool.com/investing/general/2009/12/01/abbott-makes-all-the-right-moves.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/3990717281Tue, 1 Dec 2009 19:32:05 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091201/eu_britain_glaxosmithkline.html?.v=1Pharmaceuticals maker GlaxoSmithKline PLC said Tuesday it has bought a 19 percent stake in South Africa's Aspen Pharmacare Holdings, part of an effort to diversify its business to compete with generic copies of its drugs.yahoo_finance/1647304298Tue, 1 Dec 2009 10:35:12 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091110/20091110006385.html?.v=1TORONTO----Biovail Corporation today announced that the Company will participate at the Credit Suisse 18th Annual Global Healthcare Conference at the Arizona Biltmore Resort in Phoenix, Arizona and at the Lazard Capital Markets 6th Annual Healthcare Conference at the St.yahoo_finance/4025595333Tue, 10 Nov 2009 18:57:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/a/r/b/bvf.htmlyahoo_finance/3299651993Sun, 8 Nov 2009 14:19:40 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091105/us_earns_biovail.html?.v=1Drugmaker Biovail Corp. said Thursday its third-quarter profit fell 17 percent, mainly on costs related to the buyout of Prestwick Pharmaceuticals over a year ago and for commercialization rights to several drugs.yahoo_finance/3432555884Thu, 5 Nov 2009 15:13:54 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/cc/5/108655.htmlyahoo_finance/289816493Thu, 5 Nov 2009 13:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/research/earncal/20091105.html?t=bvfyahoo_finance/1422061550Thu, 5 Nov 2009 12:07:35 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091105/20091105005305.html?.v=1TORONTO----Biovail Corporation today announced financial results for the three-month and nine-month periods ended September 30, 2009. To the extent that this news release contains forward-looking statements, investors are cautioned that these statements are based on the Company’s current views, and actual outcomes are not certain.yahoo_finance/14033804Thu, 5 Nov 2009 12:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091105/20091105005302.html?.v=1TORONTO----Biovail Corporation today announced that the Company’s Board of Directors has declared a quarterly cash dividend of US$0.09 per share payable on January 4, 2010 to shareholders of record at the close of business December 2, 2009.yahoo_finance/924265331Thu, 5 Nov 2009 11:59:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091023/20091023005472.html?.v=1TORONTO----Biovail Corporation today announced that it will host a conference call and webcast on Thursday, November 5, 2009 at 8:30a.m. for Company executives to discuss third-quarter 2009 financial and operational results.yahoo_finance/1906952727Fri, 23 Oct 2009 14:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/investopedia/rss/SIG=139s3kmh4/*http%3A//stocks.investopedia.com/stock-analysis/2009/A-Dream-ADR-Portfolio-BVF-ERJ-MBT-VIP-COV1021.aspx?partner=YahooSAyahoo_finance/3580226003Wed, 21 Oct 2009 19:27:39 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091007/174882.html?.v=1DALLAS -- StockPreacher.com announces an investment report featuring DepoMed Inc. . The report includes financial and investment analysis, analyst consensus, and pertinent industry information you need to know to make an educated investment decision.yahoo_finance/4037612217Wed, 7 Oct 2009 10:50:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12ir5ht2e/*http%3A//www.marketwatch.com/news/story/mannkind-tanks-acadia-rallies/story.aspx?guid=%7BD8BFBD07%2D976D%2D45CB%2DB8F2%2D1AA572A3C184%7D&siteid=yhoofDrug stocks advance while shares of Mannkind Corp. tank after it reveals in a regulatory filing that it does not foresee entering into a marketing partnership for its inhaled insulin product before the end of the year.yahoo_finance/1513491776Tue, 6 Oct 2009 16:17:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=13d2b02r0/*http%3A//www.thestreet.com/_yahoo/story/10607683/1/mannkind-falls-on-talk-of-partner-fda-delay-biobuzz.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/3163816904Tue, 6 Oct 2009 14:18:12 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091006/us_biovail_acadia_study.html?.v=1Canadian biotechnology company Biovail Corp. and Acadia Pharmaceuticals Inc. said Tuesday they will continue to develop pimavanserin as a potential Parkinson's disease treatment, despite failures in one late-stage study.yahoo_finance/2235402766Tue, 6 Oct 2009 11:43:48 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=139i5hir7/*http%3A//www.thestreet.com/_yahoo/story/10607527/1/no-lupus-confab-invite-for-immunomedics-biobuzz.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/2868055151Tue, 6 Oct 2009 11:42:17 Etc/GMT